Connect with us

Headlines of The Day

Krsnaa Diagnostics Q4FY24: PAT Rs 187 million, revenue Rs 1663M

Krsnaa Diagnostics announced Q4FY24 results.

PAT was Rs 187 million in Q4FY24 compared to Rs 189 million in Q4FY23.

Revenue from operations was Rs 1,663 million in Q4FY24 compared to Rs 1,332 million in Q4FY23.

EBITDA was Rs 445 million in Q4FY24 compared to Rs 348 million in Q4FY23.

Diluted earnings per share from continuing operations were Rs 5.7 compared to Rs 5.88 a year ago.

FY24 highlights
Revenue from Operations was up 27% YoY to Rs. 6,196 million against Rs 4,871 million in FY23

Profit After Tax was Rs. 568 million in Q4FY24 against Rs 621 million in Q4FY23.

EBITDA was Rs. 1,461 million, representing an 18% YoY growth with a 24% margin

“I am pleased to announce the outstanding results for the quarter and financial year 2024 which align with our strategic growth plans. Krsnaa Diagnostics is uniquely positioned to capitalize on the burgeoning growth trends in the diagnostics Industry. We are thrilled to announce a historic milestone in India: Krsnaa Diagnostics is the first ever lab operating in a government location to receive the prestigious CAP accreditation, setting a new benchmark for excellence in the industry,” said Yash Mutha, Joint Managing Director.

“The CAP accreditation is a testament to our commitment to quality and excellence in diagnostic services. We have recently secured a significant agreement with the Maharashtra Government for the installation and operation of 17 MRI and 17 CT machines, which is India’s one of the largest MRI tenders and further cement our leadership in the industry.”
MB Bureau

Copyright © 2024 Medical Buyer

error: Content is protected !!